Patient Safety: is the prevention of harm to patients. Emphasis is often placed on the system of care delivery that prevents errors, learns from the errors that occur and is built on a culture of safety that involves health care professionals, organizations and patients. Patient safety practices have been defined as those that reduce the risk of adverse events related to exposure to medical care across a range of diagnoses or conditions.
The MOM program had a goal of balancing costs to spread the compounding process throughout the day. This opened the doors to optimizing generator supply based on demand patterns.
...
There is no debating that a storm is approaching in our industry and it will have long lasting impacts on NPS, our customers and the patients we all work to serve. We all take these changes a...
The Centers for Medicare and Medicaid Services (CMS) is about to gather reimbursement data from laboratories to recalculate the clinical laboratory fee schedule. The process and potenti...
Patient Blood Management (PBM) is an emerging clinical concept designed to reduce unnecessary, excessive and avoidable blood transfusions. Interest in PBM has grown rapidly throughout t...
Big data has been with us for a long time, and tools to explore it continue to improve. Where are these data resources, how are we using them, and what are we finding as we explore them...
Protein aggregates can impact patient safety. This is especially important in the Biotech industry. Regulatory agencies are very worried about protein aggregates. Dr. Stoner breaks his webina...
The advent of the microarray technology in 2000 has paved the way for advanced translational research methods that use molecular markers such as microRNA, proteins, metabolites and copy numbe...
DATE: February 3rd, 2016
TIME: 10am pacific time, 1pm eastern time
Instituting a laboratory outreach program achieves a multitude of benefits beyond driving optimization, test...
Why did we change focus from the 3Rs to Systematic Reviews? Questionnaires on the 3Rs have revealed that the 3R search gets no high priority and the 3R search process is never included in fun...
Basic research in Proteomics has led to new understanding of proteins’ contributions to health and disease, and has also driven the advancement of powerful analytical technologies used...
The burgeoning area of molecular risk assessment (gene expression profiling and/or proteomic tests) in the diagnosis and treatment of prostate cancer is rapidly illuminating how clinicians mi...
DATE: July 22, 2015TIME: 9:00AM PT, 12:00PM ETHuman induced pluripotent stem cells (iPSCs) bring human biology into pre-clinical aspects of drug discovery. iPSC-derived cardiomyocytes have em...
In the case of Breast Cancer, the patient's cancer is usually detected by a mammogram or palpitation of an experienced Physician. However, these first indications that something is wrong must...
Errors in healthcare can have catastrophic results for patients. Work settings with a strong interdisciplinary teamwork culture can decrease the opportunities for errors to occur. Teamwork co...
Appropriate utilization of laboratory testing is important for the quality and safety in the healthcare system and to assist in the control of unnecessary costs in the healthcare system. Per...
CMS continues to make changes to how all healthcare providers are reimbursed in attempts to control the cost of the services provided to Medicare beneficiaries. This has led to value-based r...
Human malignant glioma is a uniformly fatal disease, causing over 14,000 deaths in the US this year. Adults diagnosed with malignant brain tumors have a median survival of approximately 15 mo...
Six-Sigma quality is defined as 3.4 (or fewer) defects per million opportunities (DPMO). Achieving Six-Sigma quality in a clinical laboratory is extremely difficult. This presentation will sh...
The use of ultrahigh throughput diagnostic tests that determine genetic sequence variation to guide patient care is rapidly expanding, fueled by the enormous growth in sequencing platform dev...
The MOM program had a goal of balancing costs to spread the compounding process throughout the day. This opened the doors to optimizing generator supply based on demand patterns.
...
There is no debating that a storm is approaching in our industry and it will have long lasting impacts on NPS, our customers and the patients we all work to serve. We all take these changes a...
The Centers for Medicare and Medicaid Services (CMS) is about to gather reimbursement data from laboratories to recalculate the clinical laboratory fee schedule. The process and potenti...
Patient Blood Management (PBM) is an emerging clinical concept designed to reduce unnecessary, excessive and avoidable blood transfusions. Interest in PBM has grown rapidly throughout t...
Big data has been with us for a long time, and tools to explore it continue to improve. Where are these data resources, how are we using them, and what are we finding as we explore them...
Protein aggregates can impact patient safety. This is especially important in the Biotech industry. Regulatory agencies are very worried about protein aggregates. Dr. Stoner breaks his webina...
The advent of the microarray technology in 2000 has paved the way for advanced translational research methods that use molecular markers such as microRNA, proteins, metabolites and copy numbe...
DATE: February 3rd, 2016
TIME: 10am pacific time, 1pm eastern time
Instituting a laboratory outreach program achieves a multitude of benefits beyond driving optimization, test...
Why did we change focus from the 3Rs to Systematic Reviews? Questionnaires on the 3Rs have revealed that the 3R search gets no high priority and the 3R search process is never included in fun...
Basic research in Proteomics has led to new understanding of proteins’ contributions to health and disease, and has also driven the advancement of powerful analytical technologies used...
The burgeoning area of molecular risk assessment (gene expression profiling and/or proteomic tests) in the diagnosis and treatment of prostate cancer is rapidly illuminating how clinicians mi...
DATE: July 22, 2015TIME: 9:00AM PT, 12:00PM ETHuman induced pluripotent stem cells (iPSCs) bring human biology into pre-clinical aspects of drug discovery. iPSC-derived cardiomyocytes have em...
In the case of Breast Cancer, the patient's cancer is usually detected by a mammogram or palpitation of an experienced Physician. However, these first indications that something is wrong must...
Errors in healthcare can have catastrophic results for patients. Work settings with a strong interdisciplinary teamwork culture can decrease the opportunities for errors to occur. Teamwork co...
Appropriate utilization of laboratory testing is important for the quality and safety in the healthcare system and to assist in the control of unnecessary costs in the healthcare system. Per...
CMS continues to make changes to how all healthcare providers are reimbursed in attempts to control the cost of the services provided to Medicare beneficiaries. This has led to value-based r...
Human malignant glioma is a uniformly fatal disease, causing over 14,000 deaths in the US this year. Adults diagnosed with malignant brain tumors have a median survival of approximately 15 mo...
Six-Sigma quality is defined as 3.4 (or fewer) defects per million opportunities (DPMO). Achieving Six-Sigma quality in a clinical laboratory is extremely difficult. This presentation will sh...
The use of ultrahigh throughput diagnostic tests that determine genetic sequence variation to guide patient care is rapidly expanding, fueled by the enormous growth in sequencing platform dev...
Follow
